The NF-B subunit, Rel A, is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukaemia and represents a promising therapeutic target.

Saman Hewamana, Suhair Alghazal, Thet Thet Lin, Matthew Clement, Chris Jenkins, Monica L. Guzman, Craig T Jordan, Sundar Neelakantan, Peter A Crooks, Alan K Burnett, Guy Pratt, Chris Fegan, Clare Rowntree, Paul Brennan, Chris Pepper

Research output: Contribution to journalArticle

127 Citations (Scopus)

Fingerprint Dive into the research topics of 'The NF-B subunit, Rel A, is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukaemia and represents a promising therapeutic target.'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds